The effects of concomitant GERD, dyspepsia, and rhinosinusitis on asthma symptoms and FeNO in asthmatic patients taking controller medications

• Published in: Journal of asthma and allergy 2014-01, Vol.7 (default), p.131-139
• Main Authors: Ishizuka, Tamotsu, Hisada, Takeshi, Kamide, Yosuke, Aoki, Haruka, Seki, Kaori, Honjo, Chisato, Sakai, Hiroyuki, Kadowaki, Maiko, Umeda, Yukihiro, Morikawa, Miwa, Anzai, Masaki, Ameshima, Shingo, Ishizaki, Takeshi, Dobashi, Kunio, Yamada, Masanobu, Kusano, Motoyasu
• Format: Article
• Language: English
• Subjects: Asthma; Daytime; Diagnosis; Drug dosages; Dyspepsia; Endoscopy; Esophagus; Gastroenterology; Gastroesophageal reflux; Health aspects; Hospitals; Inflammation; Leukocytes (eosinophilic); Medicine; Nitric oxide; Olfaction; Original Research; Patients; Physiological aspects; Quality of life; Questionnaires; Respiratory tract; Respiratory tract diseases; Rhinitis; Rhinosinusitis; Sinusitis
• ISSN: 1178-6965; 1178-6965
• DOI: 10.2147/jaa.s67062

Losing the sense of smell, which suggests eosinophilic rhinosinusitis, is a subjective symptom, sometimes reported in asthmatic patients taking controller medication. Upper abdominal symptoms, suggesting gastroesophageal reflux disease (GERD) or functional dyspepsia, occur also in these patients. However, the relationship between these symptoms, concomitant with asthma, and the intensity of eosinophilic airway inflammation remains obscure. To assess the symptoms of asthma and rhinosinusitis, and to examine the relationship between the symptoms and bronchial inflammation, a new questionnaire, the G scale, was developed. To investigate the effects of GERD, dyspepsia, and rhinosinusitis on asthma symptoms and bronchial inflammation, the symptoms of asthma and rhinosinusitis obtained by the G scale, upper abdominal symptoms obtained by the modified F scale, a questionnaire for GERD and dyspepsia, and fractional exhaled nitric oxide (FeNO) were analyzed. A prospective, observational study was performed in four hospitals in Gunma prefecture, and a retrospective analysis was done using data obtained from five hospitals in Gunma prefecture and Fukui prefecture, Japan. A total of 252 patients diagnosed as having asthma participated in the prospective study. The frequency of daytime phlegm or losing the sense of smell had a positive correlation with FeNO levels in asthmatic patients taking controller medication. Upper abdominal symptoms, as well as symptoms suggesting rhinitis, were well correlated with asthma symptoms. However, neither upper abdominal symptoms nor rhinitis symptoms increased FeNO levels, which reflect eosinophilic airway inflammation during treatment for asthma. On the other hand, the degree of upper abdominal symptoms or dyspepsia symptoms had a weak but significant negative correlation with FeNO levels. Daytime phlegm and losing the sense of smell suggest that eosinophilic airway inflammation persists, despite anti-inflammatory therapy, in patients with asthma. Although rhinitis and GERD made the subjective symptoms of asthma worse, they did not seem to enhance eosinophilic airway inflammation.